Wiener klinische Wochenschrift Education

, Volume 6, Issue 4, pp 113–128

Onkologische Notfälle



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007;25: 3274–3280PubMedCrossRefGoogle Scholar
  2. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst 2011;103: 117–128PubMedCrossRefGoogle Scholar
  3. Behl D, Hendrickson AW, Moynihan TJ. Oncologic emergencies. Crit Care Clin 2010;26: 181–205PubMedCrossRefGoogle Scholar
  4. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice: Superior vena cava syndrome with malignant causes. N Engl J Med 2007;356: 1862–1869PubMedCrossRefGoogle Scholar
  5. Urban T, Lebeau B, Chastang C, et al. Superior vena cava syndrome in small-cell lung cancer. Arch Intern Med 1993;153: 384–387PubMedCrossRefGoogle Scholar
  6. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2004;85: 37–42Google Scholar
  7. Bach F, Larsen BH, Rohde K, et al. Metastatic spinal cord compression, occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir 1990;107: 37–43CrossRefGoogle Scholar
  8. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol 2008;7: 459–466PubMedCrossRefGoogle Scholar
  9. Sorenson PS, Helweg-Larsen S, Mouridsen H, et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomized trial. Eur J Cancer 1994;30A: 22–27CrossRefGoogle Scholar
  10. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366: 643–648PubMedCrossRefGoogle Scholar
  11. Peacock KH, Lesser GJ. Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol 2007;7: 479–489CrossRefGoogle Scholar
  12. Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: a comprehensive review. Crit Rev Oncol Hematol 2004;52: 199–215PubMedCrossRefGoogle Scholar
  13. Sirven JI, Wingerchuk DM, Drazkowski JF, et al. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004;79: 1489–1494PubMedCrossRefGoogle Scholar
  14. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004;75 (Suppl 3): iii22–28PubMedCrossRefGoogle Scholar
  15. Funk GC, Lindner G, Druml W, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med 2010;36: 304–311PubMedCrossRefGoogle Scholar
  16. Esposito P, Piotti G, Bianzina S, et al. The Syndrome of Inappropriate Antidiuresis: Pathophysiology, Clinical Management and New Therapeutic Options. Nephron Clin Pract 2011;119: c62–c73PubMedCrossRefGoogle Scholar
  17. Schrier RW, Gross P, Gheorghiade M, et al; SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355: 2099–112PubMedCrossRefGoogle Scholar
  18. Menger H, Jorg J. Outcome of central pontine and extrapontine myelinolysis. J Neurol 1999;246: 700–705PubMedCrossRefGoogle Scholar
  19. Lee CT, Yang CC, Lam KK, et al. Hypercalcemia in the emergency department. Am J Med Sci 2006;331: 119–123PubMedCrossRefGoogle Scholar
  20. Ralston SH, Gallacher SJ, Patel U, et al. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990;112: 499–504PubMedGoogle Scholar
  21. Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008;26: 2767–2778PubMedCrossRefGoogle Scholar
  22. Cairo MS, Coiffier B, Reiter A, et al; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010;149: 578–586PubMedCrossRefGoogle Scholar
  23. Coiffier B. Acute tumor lysis syndrome - a rare complication in the treatment of solid tumors. Onkologie 2010;33: 498–499PubMedCrossRefGoogle Scholar
  24. Thirumala R, Ramaswamy M, Chawla S. Diagnosis and management of infectious complications in critically ill patients with cancer. Crit Care Clin 2010;26: 59–91PubMedCrossRefGoogle Scholar
  25. Bodey GP, Buckley M, Sathe YS, et al (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64: 328–340PubMedGoogle Scholar
  26. Burgmann H. Prevention and therapy of infections in tumor patients. Wien Med Wochenschr 2001;151: 600–614PubMedGoogle Scholar
  27. Link H, Böhme A, Cornely OA, et al; Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO); Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol2003; 82 (Suppl 2): S105–S117PubMedCrossRefGoogle Scholar
  28. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of anatimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34: 730–751PubMedCrossRefGoogle Scholar
  29. Vandijck DM, Benoit DD, Depuydt PO, et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008;34: 847–855PubMedCrossRefGoogle Scholar
  30. Pène F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008;36: 690–696PubMedCrossRefGoogle Scholar
  31. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36: 296–327PubMedCrossRefGoogle Scholar
  32. Pastores SM, Voigt LP. Acute respiratory failure in the patient with cancer: diagnostic and management strategies. Crit Care Clin 2010;26: 21–40PubMedCrossRefGoogle Scholar
  33. Azoulay E, Thiéry G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004;83: 360–370CrossRefGoogle Scholar
  34. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010;182: 1038–1046PubMedCrossRefGoogle Scholar
  35. Maschmeyer G, Beinert T, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 2009; 45: 2462–2472PubMedCrossRefGoogle Scholar
  36. download 08.08.2011

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Arbeitsgruppe für hämato-onkologische Intensivmedizin, Intensivstation 13i2, Universitätsklinik für Innere Medizin IMedizinische Universität WienWienAustria

Personalised recommendations